ABERNETHY MATT 内部人交易：近期 SEC Form 4 交易
过去 18 个月，ABERNETHY MATT（CIK 1724097）在 1 家公司共报告 14 笔 SEC Form 4 内部人交易（最近一笔 2026-09-15）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-09-15 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | 买入 | 5,020 | $0 |
| 2026-09-15 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | 卖出 | 2,709 | $423,200 |
| 2026-09-15 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | 卖出 | 2,311 | $363,285 |
| 2026-03-05 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | 卖出 | 2,249 | $0 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | 买入 | 2,133 | $0 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | 卖出 | 1,151 | $141,688 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | 买入 | 2,241 | $0 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | 卖出 | 1,210 | $150,185 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | 买入 | 2,566 | $0 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | 卖出 | 1,385 | $171,906 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | 买入 | 9,968 | $0 |
| 2026-02-17 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | 卖出 | 5,378 | $667,517 |
| 2026-02-03 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | 买入 | 2,437 | $0 |
| 2026-02-03 | NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Financial Officer | 卖出 | 1,368 | $186,130 |
来源：SEC Form 4 申报文件 · 截至 2026-09-15